Join
Live feed
·
ANALYSTRatingvia Quantisnow
CRISPR Therapeutics AG logo

Guggenheim resumed coverage on CRISPR Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
CRSP· CRISPR Therapeutics AG
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.